Molecular Cancer Pathology Professor Simon Herrington Professor of Molecular Pathology of Cancer Contact details Email: Simon.Herrington@ed.ac.uk Research in a Nutshell My main research focus is the development of optical imaging for the early detection of epithelial neoplasia. I have a long-standing optical imaging collaboration with the School of Physics and Astronomy in St Andrews, which focuses on technology that can discriminate between normal and neoplastic cells and tissues. I am part of the Engineering and Physical Sciences Research Council (EPSRC) and MRC Centre for Doctoral Training in Optical Imaging (OPTIMA), through which I have a collaboration with Strathclyde University, and I am also working with Edinburgh Medical Imaging. These collaborations all aim to develop novel optical approaches to cancer diagnosis. I am also part of the Nicola Murray Centre for Ovarian Cancer Research (Prof Charlie Gourley), with current projects including the molecular investigation of high-grade serous carcinoma of the ovary and the characterization of endometrioid and clear cell ovarian carcinomas. I am Editor in Chief of The Journal of Pathology and The Journal of Pathology: Clinical Research. My research interests are aligned with my clinical practice in gynaecological pathology as a Consultant Pathologist with NHS Lothian. People NameRole Simon HerringtonPrincipal Investigator and Professor of Molecular Pathology of CancerEmily SouthworthPhD student Key Publications Simon Herrington Research Explorer Profile Collaborations Prof Kishan Dholakia, Physics and Astronomy, University of St AndrewsProf Duncan Graham, Chemistry, University of StrathclydeEdinburgh Medical Imaging Website Links Full publication listThe Journal of Pathology WebsiteThe Journal of Pathology: Clinical Research Website Partners and Funders Wellcome Trust ISSF2 award (£65K; 2016). Comparative pathology analysis of gene expression in animal and human tissues by high throughput in-situ hybridization (Co-investigator) (with M Arends, M Cheeseman)Medical Research Scotland (£107,677; 2016-2020). Novel theranostic agents for enhanced diagnosis and minimally invasive therapy of cervical cancer (Co-supervisor) (with M Vendrell and Edinburgh Medical Imaging)Medical Research Council (£2.1M; 2015 – 2018): Edinburgh – St. Andrews Consortium for Molecular Pathology, Informatics and Genome Science (Co-investigator and lead for Masters programme in Molecular Pathology) (with T Aitman (PI), D Harrison and others) Scientific Themes Cancer, gynaecology, ovary, cervix, optical imaging Technology Expertise Pathology, digital pathology, molecular investigation of human tissue This article was published on 2024-09-23